Source link : https://newshealth.biz/health-news/mosunetuzumab-in-dlbcl-shows-promise-as-frontline-option-for-elderly-patients/
(MedPage Today) — At the recent American Society of Hematology (ASH) meeting, researchers presented early data from a phase II study evaluating mosunetuzumab (Lunsumio) as frontline monotherapy for elderly patients with diffuse large B-cell lymphoma… Source link : https://www.medpagetoday.com/meetingcoverage/ashfuturefocusdlbcl/119036 Author : Publish date : 2025-12-16 15:38:00 Copyright for syndicated content belongs to the linked Source.
The post Mosunetuzumab in DLBCL Shows Promise as Frontline Option for Elderly Patients first appeared on News Health.
—-
Author : News Health
Publish date : 2025-12-16 15:38:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8